Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Schibsted Tillväxtmedier in connection with its divestment of Prisjakt
Mandate

Vinge advises Schibsted Tillväxtmedier in connection with its divestment of Prisjakt

May 06, 2025 M&A Employment and Benefits Data protection and processing of personal data Intellectual Property Commercial Agreements

Schibsted Tillväxtmedier has entered into an agreement for the sale of Prisjakt to eEquity. The consideration is expected to amount to around SEK 500 million. Schibsted has owned Prisjakt for approximately 20 years and the divestment is made as part of Schibsted’s ongoing streamlining of its organisation and portfolio.

The transaction is expected to close in June 2025 and is conditional upon approval from the Swedish Competition Authority.

Vinge’s team consisted mainly of Johan Larsson, Johan Winnerblad and Gustav Wahlberg (M&A), Nicklas Thorgerzon (GDPR), Eva Fredrikson, Christoffer Nordin, Siri Blomberg and Carl Lexenberg (Kommersiella avtal), Alice Göransson (Commercial agreements) as well as Johan Gavelin (IP).

Related

Vinge has advised Studentbostäder i Norden AB in connection with its rights issue

 Vinge has advised Studentbostäder i Norden AB (publ), a real estate company whose shares are listed on Nasdaq First North Premier Growth Market, in connection with an oversubscribed rights issue amounting to approximately SEK 145 million before deduction of transaction costs.
April 25, 2025

Vinge advises Axcel and Accru Partners in connection with the acquisitions of Carlstedt & Lindh AB and Brahe Revisionsbyrå AB

 Vinge has advised Axcel VII and Accru Partners in connection with the acquisitions of Carlstedt & Lindh AB and Brahe Revisionsbyrå AB
April 24, 2025

Vinge advises Biotage in connection with RWK Bidco’s public tender

On 22 April 2025, RWK Bidco AB, a newly formed company indirectly wholly owned by KKR Funds, announced a public tender offer to the shareholders in Biotage AB to tender all ordinary shares in Biotage to RWK Bidco at a price of SEK 145 in cash per ordinary share.
April 22, 2025